This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Defense Threat Reduction Agency, US Dod, Harvard College, Massachusetts Institute of Technology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Nicolaas Angenent-Mari: Innovator in Riboregulators and Hydrogels
Introduction
Nicolaas Angenent-Mari is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of riboregulators and hydrogels. With a total of 2 patents, his work has the potential to impact medical diagnostics and treatment.
Latest Patents
One of his latest patents is titled "Riboregulators and methods of use thereof." This disclosure provides riboregulators specific for particular viruses or for specific human transcription factors. The viral-specific riboregulators may be used to detect the presence of a particular virus, enabling the diagnosis of an infection. Additionally, the transcription factor-specific riboregulators may be utilized to detect the presence and/or measure the level of specific transcription factors, which can aid in diagnosing or prognosing conditions such as cancer. Another significant patent is "DNA-Responsive Hydrogels," which showcases his innovative approach to creating responsive materials for various applications.
Career Highlights
Throughout his career, Nicolaas has worked with prestigious institutions such as Harvard College and the Massachusetts Institute of Technology. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable coworkers is Luis Ruben Soenksen Martinez, with whom he has collaborated on various projects. Their combined expertise has led to advancements in the understanding and application of riboregulators and hydrogels.
Conclusion
Nicolaas Angenent-Mari's innovative work in riboregulators and hydrogels positions him as a key figure in biotechnology. His contributions have the potential to enhance medical diagnostics and treatment options, making a lasting impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile